122 related articles for article (PubMed ID: 34862331)
1. Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension.
Li C; Ma L; Wang Q; Shao X; Guo L; Chen J; Wang W; Yu J
J Hypertens; 2022 Apr; 40(4):675-684. PubMed ID: 34862331
[TBL] [Abstract][Full Text] [Related]
2. Research on the Mechanism and Prevention of Hypertension Caused by Apatinib Through the RhoA/ROCK Signaling Pathway in a Mouse Model of Gastric Cancer.
Wang W; He Q; Li C; Zhuang C; Zhang H; Wang Q; Fan X; Qi M; Sun R; Yu J
Front Cardiovasc Med; 2022; 9():873829. PubMed ID: 35811723
[TBL] [Abstract][Full Text] [Related]
3. Apatinib Through Activating the RhoA/ROCK Signaling Pathway to Cause Dysfunction of Vascular Smooth Muscle Cells.
Wang W; He Q; Zhuang C; Zhang H; Fan X; Wang Q; Qi M; Sun R; Li C; Yu J
Appl Biochem Biotechnol; 2022 Nov; 194(11):5367-5385. PubMed ID: 35776338
[TBL] [Abstract][Full Text] [Related]
4. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
[TBL] [Abstract][Full Text] [Related]
5. Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.
Lee TM; Chung TH; Lin SZ; Chang NC
J Hypertens; 2014 Apr; 32(4):795-805. PubMed ID: 24463935
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
7. Alkaloids from Nelumbinis Plumula (AFNP) ameliorate aortic remodeling via RhoA/ROCK pathway.
Li Q; Wo D; Huang Y; Yu N; Zeng J; Chen H; Wang H; Bao L; Lin S; Chu J; Peng J
Biomed Pharmacother; 2019 Apr; 112():108651. PubMed ID: 30784931
[TBL] [Abstract][Full Text] [Related]
8. The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia.
Lu W; Kang J; Hu K; Tang S; Zhou X; Xu L; Li Y; Yu S
Sleep Breath; 2017 Sep; 21(3):667-677. PubMed ID: 28078487
[TBL] [Abstract][Full Text] [Related]
9. Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
Behuliak M; Vavřínová A; Bencze M; Polgárová K; Ergang P; Kuneš J; Vaněčková I; Zicha J
J Hypertens; 2015 Dec; 33(12):2443-54. PubMed ID: 26418671
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin attenuated cerebrovascular cell proliferation in the development of hypertension through Rho/Rho-kinase pathway.
Ma MM; Li SY; Wang M; Guan YY
J Cardiovasc Pharmacol; 2012 Jun; 59(6):576-82. PubMed ID: 22392066
[TBL] [Abstract][Full Text] [Related]
11. Dexfenfluramine discontinuous treatment does not worsen hypoxia-induced pulmonary vascular remodeling but activates RhoA/ROCK pathway: consequences on pulmonary hypertension.
Desbuards N; Antier D; Rochefort GY; Apfeldorfer CS; Schenck E; Hanton G; Hyvelin JM
Eur J Pharmacol; 2009 Jan; 602(2-3):355-63. PubMed ID: 19049806
[TBL] [Abstract][Full Text] [Related]
12. RhoA-Rho kinase signaling mediates endothelium- and endoperoxide-dependent contractile activities characteristic of hypertensive vascular dysfunction.
Denniss SG; Jeffery AJ; Rush JW
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1391-405. PubMed ID: 20154258
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol prevents AngII-induced hypertension via AMPK activation and RhoA/ROCK suppression in mice.
Cao X; Luo T; Luo X; Tang Z
Hypertens Res; 2014 Sep; 37(9):803-10. PubMed ID: 24965170
[TBL] [Abstract][Full Text] [Related]
14. RhoA/ROCK signaling regulates smooth muscle phenotypic modulation and vascular remodeling via the JNK pathway and vimentin cytoskeleton.
Tang L; Dai F; Liu Y; Yu X; Huang C; Wang Y; Yao W
Pharmacol Res; 2018 Jul; 133():201-212. PubMed ID: 29791873
[TBL] [Abstract][Full Text] [Related]
15. Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway.
Fibbi B; Morelli A; Marini M; Zhang XH; Mancina R; Vignozzi L; Filippi S; Chavalmane A; Silvestrini E; Colli E; Adorini L; Vannelli GB; Maggi M
J Androl; 2008; 29(1):70-84. PubMed ID: 17699803
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine inhibits monocrotaline-induced pulmonary arterial remodeling involved in inhibition of RhoA-Rho kinase and Akt signalling pathways in rats.
Wang HM; Wang Y; Liu M; Bai Y; Zhang XH; Sun YX; Wang HL
Can J Physiol Pharmacol; 2012 Nov; 90(11):1506-15. PubMed ID: 23181278
[TBL] [Abstract][Full Text] [Related]
17. Tacrolimus Causes Hypertension by Increasing Vascular Contractility via RhoA (Ras Homolog Family Member A)/ROCK (Rho-Associated Protein Kinase) Pathway in Mice.
Wang X; Jiang S; Fei L; Dong F; Xie L; Qiu X; Lei Y; Guo J; Zhong M; Ren X; Yang Y; Zhao L; Zhang G; Wang H; Tang C; Yu L; Liu R; Patzak A; Persson PB; Hultström M; Wei Q; Lai EY; Zheng Z
Hypertension; 2022 Oct; 79(10):2228-2238. PubMed ID: 35938417
[TBL] [Abstract][Full Text] [Related]
18. Salicylates dilate blood vessels through inhibiting PYK2-mediated RhoA/Rho-kinase activation.
Ying Z; Giachini FR; Tostes RC; Webb RC
Cardiovasc Res; 2009 Jul; 83(1):155-62. PubMed ID: 19276129
[TBL] [Abstract][Full Text] [Related]
19. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of aloperin on monocroline-induced pulmonary hypertension via regulation of Rho A/Rho kinsase pathway in rats.
Wu F; Yao W; Yang J; Zhang M; Xu Y; Hao Y; Yan L; Niu Y; Sun T; Yu J; Zhou R
Biomed Pharmacother; 2017 Nov; 95():1161-1168. PubMed ID: 28926926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
